(Q87414124)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040423%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Tackling the global diabetes burden: will screening help? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040423%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040423%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Michael M Engelgau

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040423%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

language of work or name

English

0 references

publication date

4 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040423%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040423%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

380

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040423%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

9855

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040423%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

1716-1718

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040423%20AND%20SRC:MED&resulttype=core&format=json

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961682-1

7 January 2021

Prevalence of diabetes among men and women in China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961682-1

7 January 2021

Screening for type 2 diabetes: an update of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961682-1

7 January 2021

Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961682-1

7 January 2021

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961682-1

7 January 2021

Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961682-1

7 January 2021

Are lifestyle changes achieved after participation in a screening programme for Type 2 diabetes? The ADDITION Study, Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961682-1

7 January 2021

Trying to predict the future for people with diabetes: a tough but important task

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961682-1

7 January 2021

Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961682-1

7 January 2021

Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961682-1

7 January 2021

Risk identification and interventions to prevent type 2 diabetes in adults at high risk: summary of NICE guidance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961682-1

7 January 2021

Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961682-1

7 January 2021

Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961682-1

7 January 2021

10.1016/S0140-6736(12)61682-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040423%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference